Berman Capital Advisors, LLC - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Berman Capital Advisors, LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2021$0330.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders